The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Neurological Drugs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Neurological Drugs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2029

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1751649

No of Pages : 126

Ask Your Query

Synopsis
The global Neurological Drugs market size was valued at USD 121420 million in 2022 and is forecast to a readjusted size of USD 196010 million by 2029 with a CAGR of 7.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Nervous system diseases are diseases that occur in the central nervous system, peripheral nervous system, and autonomic nervous system, mainly manifested in sensory, motor, consciousness, and autonomic dysfunction.

This report is a detailed and comprehensive analysis for global Neurological Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

  • Global Neurological Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
  • Global Neurological Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
  • Global Neurological Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
  • Global Neurological Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Neurological Drugs
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace

This report profiles key players in the global Neurological Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Ely Lilly, Actavis, Mylan and Randox, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Neurological Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

  • Non-prescription drugs
  • Prescription

Market segment by Application

  • Hospital
  • Clinic

Major players covered

  • Pfizer
  • Ely Lilly
  • Actavis
  • Mylan
  • Randox
  • Intellipharmaceutics
  • Astrazeneca
  • Lundbeck
  • Allergan
  • GSK
  • Otsuka Pharmaceutical
  • Takeda
  • NHU Group
  • Shionogi
  • APOTEX
  • North China Pharmaceutical
  • Harbin Pharmaceutical Co., Ltd.
  • Lukang Pharmaceutical
  • Kelun Pharmaceutical
  • Kehua Biology

Market segment by region, regional analysis covers

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Neurological Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Neurological Drugs, with price, sales, revenue and global market share of Neurological Drugs from 2018 to 2023.
Chapter 3, the Neurological Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neurological Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Neurological Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Neurological Drugs.
Chapter 14 and 15, to describe Neurological Drugs sales channel, distributors, customers, research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of Neurological Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Neurological Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Non-prescription drugs
1.3.3 Prescription
1.4 Market Analysis by Application
1.4.1 Overview: Global Neurological Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Neurological Drugs Market Size & Forecast
1.5.1 Global Neurological Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Neurological Drugs Sales Quantity (2018-2029)
1.5.3 Global Neurological Drugs Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Neurological Drugs Product and Services
2.1.4 Pfizer Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 Ely Lilly
2.2.1 Ely Lilly Details
2.2.2 Ely Lilly Major Business
2.2.3 Ely Lilly Neurological Drugs Product and Services
2.2.4 Ely Lilly Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Ely Lilly Recent Developments/Updates
2.3 Actavis
2.3.1 Actavis Details
2.3.2 Actavis Major Business
2.3.3 Actavis Neurological Drugs Product and Services
2.3.4 Actavis Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Actavis Recent Developments/Updates
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Neurological Drugs Product and Services
2.4.4 Mylan Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Mylan Recent Developments/Updates
2.5 Randox
2.5.1 Randox Details
2.5.2 Randox Major Business
2.5.3 Randox Neurological Drugs Product and Services
2.5.4 Randox Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Randox Recent Developments/Updates
2.6 Intellipharmaceutics
2.6.1 Intellipharmaceutics Details
2.6.2 Intellipharmaceutics Major Business
2.6.3 Intellipharmaceutics Neurological Drugs Product and Services
2.6.4 Intellipharmaceutics Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Intellipharmaceutics Recent Developments/Updates
2.7 Astrazeneca
2.7.1 Astrazeneca Details
2.7.2 Astrazeneca Major Business
2.7.3 Astrazeneca Neurological Drugs Product and Services
2.7.4 Astrazeneca Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Astrazeneca Recent Developments/Updates
2.8 Lundbeck
2.8.1 Lundbeck Details
2.8.2 Lundbeck Major Business
2.8.3 Lundbeck Neurological Drugs Product and Services
2.8.4 Lundbeck Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Lundbeck Recent Developments/Updates
2.9 Allergan
2.9.1 Allergan Details
2.9.2 Allergan Major Business
2.9.3 Allergan Neurological Drugs Product and Services
2.9.4 Allergan Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Allergan Recent Developments/Updates
2.10 GSK
2.10.1 GSK Details
2.10.2 GSK Major Business
2.10.3 GSK Neurological Drugs Product and Services
2.10.4 GSK Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 GSK Recent Developments/Updates
2.11 Otsuka Pharmaceutical
2.11.1 Otsuka Pharmaceutical Details
2.11.2 Otsuka Pharmaceutical Major Business
2.11.3 Otsuka Pharmaceutical Neurological Drugs Product and Services
2.11.4 Otsuka Pharmaceutical Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Otsuka Pharmaceutical Recent Developments/Updates
2.12 Takeda
2.12.1 Takeda Details
2.12.2 Takeda Major Business
2.12.3 Takeda Neurological Drugs Product and Services
2.12.4 Takeda Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Takeda Recent Developments/Updates
2.13 NHU Group
2.13.1 NHU Group Details
2.13.2 NHU Group Major Business
2.13.3 NHU Group Neurological Drugs Product and Services
2.13.4 NHU Group Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 NHU Group Recent Developments/Updates
2.14 Shionogi
2.14.1 Shionogi Details
2.14.2 Shionogi Major Business
2.14.3 Shionogi Neurological Drugs Product and Services
2.14.4 Shionogi Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Shionogi Recent Developments/Updates
2.15 APOTEX
2.15.1 APOTEX Details
2.15.2 APOTEX Major Business
2.15.3 APOTEX Neurological Drugs Product and Services
2.15.4 APOTEX Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 APOTEX Recent Developments/Updates
2.16 North China Pharmaceutical
2.16.1 North China Pharmaceutical Details
2.16.2 North China Pharmaceutical Major Business
2.16.3 North China Pharmaceutical Neurological Drugs Product and Services
2.16.4 North China Pharmaceutical Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 North China Pharmaceutical Recent Developments/Updates
2.17 Harbin Pharmaceutical Co., Ltd.
2.17.1 Harbin Pharmaceutical Co., Ltd. Details
2.17.2 Harbin Pharmaceutical Co., Ltd. Major Business
2.17.3 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Product and Services
2.17.4 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Harbin Pharmaceutical Co., Ltd. Recent Developments/Updates
2.18 Lukang Pharmaceutical
2.18.1 Lukang Pharmaceutical Details
2.18.2 Lukang Pharmaceutical Major Business
2.18.3 Lukang Pharmaceutical Neurological Drugs Product and Services
2.18.4 Lukang Pharmaceutical Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Lukang Pharmaceutical Recent Developments/Updates
2.19 Kelun Pharmaceutical
2.19.1 Kelun Pharmaceutical Details
2.19.2 Kelun Pharmaceutical Major Business
2.19.3 Kelun Pharmaceutical Neurological Drugs Product and Services
2.19.4 Kelun Pharmaceutical Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Kelun Pharmaceutical Recent Developments/Updates
2.20 Kehua Biology
2.20.1 Kehua Biology Details
2.20.2 Kehua Biology Major Business
2.20.3 Kehua Biology Neurological Drugs Product and Services
2.20.4 Kehua Biology Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Kehua Biology Recent Developments/Updates
3 Competitive Environment: Neurological Drugs by Manufacturer
3.1 Global Neurological Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Neurological Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Neurological Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Neurological Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Neurological Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Neurological Drugs Manufacturer Market Share in 2022
3.5 Neurological Drugs Market: Overall Company Footprint Analysis
3.5.1 Neurological Drugs Market: Region Footprint
3.5.2 Neurological Drugs Market: Company Product Type Footprint
3.5.3 Neurological Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Neurological Drugs Market Size by Region
4.1.1 Global Neurological Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Neurological Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Neurological Drugs Average Price by Region (2018-2029)
4.2 North America Neurological Drugs Consumption Value (2018-2029)
4.3 Europe Neurological Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Neurological Drugs Consumption Value (2018-2029)
4.5 South America Neurological Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Neurological Drugs Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Neurological Drugs Sales Quantity by Type (2018-2029)
5.2 Global Neurological Drugs Consumption Value by Type (2018-2029)
5.3 Global Neurological Drugs Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Neurological Drugs Sales Quantity by Application (2018-2029)
6.2 Global Neurological Drugs Consumption Value by Application (2018-2029)
6.3 Global Neurological Drugs Average Price by Application (2018-2029)
7 North America
7.1 North America Neurological Drugs Sales Quantity by Type (2018-2029)
7.2 North America Neurological Drugs Sales Quantity by Application (2018-2029)
7.3 North America Neurological Drugs Market Size by Country
7.3.1 North America Neurological Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Neurological Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Neurological Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Neurological Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Neurological Drugs Market Size by Country
8.3.1 Europe Neurological Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Neurological Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Neurological Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Neurological Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Neurological Drugs Market Size by Region
9.3.1 Asia-Pacific Neurological Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Neurological Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Neurological Drugs Sales Quantity by Type (2018-2029)
10.2 South America Neurological Drugs Sales Quantity by Application (2018-2029)
10.3 South America Neurological Drugs Market Size by Country
10.3.1 South America Neurological Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Neurological Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Neurological Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Neurological Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Neurological Drugs Market Size by Country
11.3.1 Middle East & Africa Neurological Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Neurological Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Neurological Drugs Market Drivers
12.2 Neurological Drugs Market Restraints
12.3 Neurological Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Neurological Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Neurological Drugs
13.3 Neurological Drugs Production Process
13.4 Neurological Drugs Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Neurological Drugs Typical Distributors
14.3 Neurological Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock